These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1370225)

  • 21. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against polyoma virus tumor antigens.
    Dilworth SM; Griffin BE
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1059-63. PubMed ID: 6175960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.
    Bright RK; Shearer MH; Kennedy RC
    Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H; Morrison RP; Watkins NG; Caldwell HD
    J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-reactivity of antibodies against synthetic peptides.
    Walter G; Werchau H
    J Cell Biochem; 1982; 19(2):119-25. PubMed ID: 6294132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus.
    Dalianis T; Magnusson G; Ito Y; Klein G
    J Virol; 1982 Sep; 43(3):772-7. PubMed ID: 6292460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant polyoma--vaccinia viruses: T antigen expression vectors and anti-tumor immunization agents.
    Clertant P; Kieny MP; Lecocq JP; Guizani I; Chambon P; Cuzin F; Lathe R
    Biochimie; 1988 Aug; 70(8):1075-87. PubMed ID: 2852508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
    Ferrari C; Bertoletti A; Penna A; Cavalli A; Valli A; Missale G; Pilli M; Fowler P; Giuberti T; Chisari FV
    J Clin Invest; 1991 Jul; 88(1):214-22. PubMed ID: 1711541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes.
    Lill NL; Tevethia MJ; Hendrickson WG; Tevethia SS
    J Exp Med; 1992 Aug; 176(2):449-57. PubMed ID: 1380062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunity to polyoma virus infection and tumorigenesis.
    Moser JM; Lukacher AE
    Viral Immunol; 2001; 14(3):199-216. PubMed ID: 11572632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
    Reynolds SR; Dahl CE; Harn DA
    J Immunol; 1994 Jan; 152(1):193-200. PubMed ID: 7504709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.
    Toes RE; Offringa R; Blom RJ; Melief CJ; Kast WM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7855-60. PubMed ID: 8755566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour prevention and rejection with recombinant vaccinia.
    Lathe R; Kieny MP; Gerlinger P; Clertant P; Guizani I; Cuzin F; Chambon P
    Nature; 1987 Apr 30-May 6; 326(6116):878-80. PubMed ID: 3033512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
    Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
    Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological detection of a polyoma-tumor-associated membrane antigen.
    Klein G; Ehlin B; Witz I
    Int J Cancer; 1979 May; 23(5):683-90. PubMed ID: 88422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed hypersensitivity to polyoma and "self" antigens in syngeneic mice.
    Ochałek T; Burzyński A; Cadel Z; Chłap Z; Porwit-Bóbr Z
    Neoplasma; 1987; 34(4):441-51. PubMed ID: 2821418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.